Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.22.9557

MiRNA Molecular Profiles in Human Medical Conditions: Connecting Lung Cancer and Lung Development Phenomena  

Aghanoori, Mohamad-Reza (Human Genetics Department, Shiraz University of Medical Sciences)
Mirzaei, Behnaz (Genetics Department, Science and Research Branch Islamic Azad University)
Tavallaei, Mahmood (Human Genetics Research Center, Baqiyatallah Medical Sciences University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.22, 2014 , pp. 9557-9565 More about this Journal
Abstract
MiRNAs are endogenous, single stranded ~22-nucleotide non-coding RNAs (ncRNAs) which are transcribed by RNA polymerase II and mediate negative post-transcriptional gene regulation through binding to 3'untranslated regions (UTR), possibly open reading frames (ORFs) or 5'UTRs of target mRNAs. MiRNAs are involved in the normal physiology of eukaryotic cells, so dysregulation may be associated with diseases like cancer, and neurodegenerative, heart and other disorders. Among all cancers, lung cancer, with high incidence and mortality worldwide, is classified into two main groups: non-small cell lung cancer and small cell lung cancer. Recent promising studies suggest that gene expression profiles and miRNA signatures could be a useful step in a noninvasive, low-cost and repeatable screening process of lung cancer. Similarly, every stage of lung development during fetal life is associated with specific miRNAs. Since lung development and lung cancer phenomena share the same physiological, biological and molecular processes like cell proliferation, development and shared mRNA or expression regulation pathways, and according to data adopted from various studies, they may have partially shared miRNA signature. Thus, focusing on lung cancer in relation to lung development in miRNA studies might provide clues for lung cancer diagnosis and prognosis.
Keywords
miRNA; medical conditions; lung cancer; lung development;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Dai Y, Sui W, Lan H, et al (2009). Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int, 29, 749-54.   DOI
2 de Pontual L, Yao E, Callier P, et al (2011). Germline deletion of the miR-17 approximately 92 cluster causes skeletal and growth defects in humans. Nat Genet, 43, 1026-30.   DOI
3 Dews M, Homayouni A, Yu D, et al (2006). Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet, 38, 1060-5.   DOI   ScienceOn
4 Doench JG, Sharp PA (2004). Specificity of microRNA target selection in translational repression. Genes Dev, 18, 504-11.   DOI   ScienceOn
5 Dong J, Jiang G, Asmann YW, et al (2010). MicroRNA networks in mouse lung organogenesis. PLoS One, 5, 10854.   DOI
6 Du L, Pertsemlidis A (2012). microRNA regulation of cell viability and drug sensitivity in lung cancer. Expert Opin Biol Ther, 12, 1221-39.   DOI   ScienceOn
7 Esau C, Kang X, Peralta E, et al (2004). MicroRNA-143 regulates adipocyte differentiation. J Biol Chem, 279, 52361-5.   DOI   ScienceOn
8 Fassina A, Cappellesso R, Fassan M (2011). Classification of non-small cell lung carcinoma in transthoracic needle specimens using microRNA expression profiling. Chest, 140, 1305-11.   DOI
9 Filipowicz W, Bhattacharyya SN, Sonenberg N (2008). Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet, 9, 102-14.
10 Fulci V, Scappucci G, Sebastiani GD, et al (2010). miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis. Hum Immunol, 71, 206-11.   DOI   ScienceOn
11 Akcakaya P, Ekelund S, Kolosenko I, et al (2011). miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer. Int J Oncol, 39, 311-8.
12 Almeida MI, Reis RM, Calin GA (2011). MicroRNA history: discovery, recent applications, and next frontiers. Mutat Res, 717, 1-8.   DOI   ScienceOn
13 Alsaleh G, Suffert G, Semaan N, et al (2009). Bruton's tyrosine kinase is involved in miR-346-related regulation of IL- 18 release by lipopolysaccharide-activated rheumatoid fibroblast-like synoviocytes. J Immunol, 182, 5088-97.   DOI   ScienceOn
14 Ambros V (2004). The functions of animal microRNAs. Nature, 431, 350-5.   DOI   ScienceOn
15 Bahl A, Sharma DN, Rath GK, et al (2008). Small molecular inhibitor of transforming growth factor-beta protects against development of radiation-induced lung injury. In regard to Anscher MS et al. (Int J Radiat Oncol Biol Phys 2008;71:1-9). Int J Radiat Oncol Biol Phys, 72, 630.   DOI
16 Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-97.   DOI   ScienceOn
17 Bhaskaran M, Wang Y, Zhang H, et al (2009). MicroRNA-127 modulates fetal lung development. Physiol Genomics, 37, 268-78.   DOI
18 Boehm M, Slack F (2005). A developmental timing microRNA and its target regulate life span in C. elegans. Science, 310, 1954-7.   DOI
19 Gao W, Xu J, Shu YQ (2011). miRNA expression and its clinical implications for the prevention and diagnosis of non-smallcell lung cancer. Expert Rev Respir Med, 5, 699-709.   DOI
20 Gregory PA, Bert AG, Paterson EL, et al (2008). The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol, 10, 593-601.   DOI   ScienceOn
21 Gregory RI, Shiekhattar R (2005). MicroRNA biogenesis and cancer. Cancer Res, 65, 3509-12.   DOI   ScienceOn
22 Grosshans H, Slack FJ (2002). Micro-RNAs: small is plentiful. J Cell Biol, 156, 17-21.   DOI
23 Guan P, Yin Z, Li X, et al (2012). Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues. J Exp Clin Cancer Res, 31, 54.   DOI
24 Guo Q, Wang F, Lu CQ, et al (2007). The expression of transforming growth factor beta1 and its I, II receptors in the development of rat embryo and embryonic lung. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 23, 317-9 (in Chinese).
25 He F, Zheng LL, Luo WT, et al (2014). Inferring single nucleotide polymorphisms in microRNA binding sites of lung cancerrelated infammatory genes. Asian Pac J Cancer Prev, 15, 3601-6.   DOI
26 He L, Hannon GJ (2004). MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet, 5, 522-31.   DOI   ScienceOn
27 Herbst RS, Heymach JV, Lippman SM (2008). Lung cancer. New Engl J Med, 359, 1367-80.   DOI   ScienceOn
28 Lee RC, Feinbaum RL, Ambros V (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 75, 843-54.   DOI   ScienceOn
29 Kumar MS, Erkeland SJ, Pester RE, et al (2008). Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci U S A, 105, 3903-8.   DOI
30 Lai EC, Tomancak P, Williams RW, et al (2003). Computational identification of Drosophila microRNA genes. Genome Biol, 4, 42.   DOI
31 Lee Y, Ahn C, Han J, et al (2003). The nuclear RNase III Drosha initiates microRNA processing. Nature, 425, 415-9.   DOI   ScienceOn
32 Lee Y, Jeon K, Lee JT, et al (2002). MicroRNA maturation: stepwise processing and subcellular localization. EMBO J, 21, 4663-70.   DOI   ScienceOn
33 Lee YS, Dutta A (2007). The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev, 21, 1025-30.   DOI   ScienceOn
34 Li Y, Zhang D, Chen C, et al (2012). MicroRNA-212 displays tumor-promoting properties in non-small cell lung cancer cells and targets the hedgehog pathway receptor PTCH1. Mol Biol Cell, 23, 1423-34.   DOI
35 Lim LP, Lau NC, Garrett-Engele P, et al (2005). Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature, 433, 769-73.   DOI   ScienceOn
36 Lin CW, Chang YL, Chang YC, et al (2013). MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1. Nat Commun, 4, 1877.   DOI
37 Lin PY, Yang PC (2011). Circulating miRNA signature for early diagnosis of lung cancer. EMBO Mol Med, 3, 436-7.   DOI
38 Mattes J, Collison A, Foster PS (2008). Emerging role of microRNAs in disease pathogenesis and strategies for therapeutic modulation. Curr Opin Mol Ther, 10, 150-7.
39 Markou A, Sourvinou I, Vorkas PA, et al (2013). Clinical evaluation of microRNA expression profiling in non small cell lung cancer. Lung Cancer.
40 Martino S, di Girolamo I, Orlacchio A, et al (2009). MicroRNA implications across neurodevelopment and neuropathology. J Biomed Biotechnol, 2009, 654346.
41 Mencia A, Modamio-Hoybjor S, Redshaw N, et al (2009). Mutations in the seed region of human miR-96 are responsible for nonsyndromic progressive hearing loss. Nat Genet, 41, 609-13.   DOI
42 Motsch N, Pfuhl T, Mrazek J, et al (2007). Epstein-Barr virusencoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a. RNA Biol, 4, 131-7.   DOI   ScienceOn
43 Mraz M, Pospisilova S (2012). MicroRNAs in chronic lymphocytic leukemia: from causality to associations and back. Expert Rev Hematol, 5, 579-81.   DOI
44 Mujahid S, Logvinenko T, Volpe MV, et al (2013). miRNA regulated pathways in late stage murine lung development. BMC Dev Biol, 13, 13.   DOI
45 Nestle FO, Kaplan DH, Barker J (2009). Psoriasis. N Engl J Med, 361, 496-509.   DOI   ScienceOn
46 O'Donnell KA, Wentzel EA, Zeller KI, et al (2005). c-Mycregulated microRNAs modulate E2F1 expression. Nature, 435, 839-43.   DOI   ScienceOn
47 Pauley KM, Cha S, Chan EK (2009). MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun, 32, 189-94.   DOI   ScienceOn
48 Yu SL, Chen HY, Chang GC, et al (2008). MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell, 13, 48-57.   DOI   ScienceOn
49 Xu TP, Zhu CH, Zhang J, et al (2013). MicroRNA-155 expression has prognostic value in patients with non-small cell lung cancer and digestive system carcinomas. APJCP, 14, 7085-90.   과학기술학회마을   DOI   ScienceOn
50 Yi R, Qin Y, Macara IG, et al (2003). Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev, 17, 3011-6.   DOI   ScienceOn
51 Zhang TF, Cheng KW, Shi WY, et al (2012). MiRNA synergistic network construction and enrichment analysis for common target genes in small-cell lung cancer. Asian Pac J Cancer Prev, 13, 6375-8.   DOI
52 Zhao Y, Chen X, Jing M, et al (2012). Expression of miRNA- 146a in nasopharyngeal carcinoma is upregulated by Epstein-Barr virus latent membrane protein 1. Oncol Rep, 28, 1237-42.
53 Zhao Y, Ransom JF, Li A, et al (2007). Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell, 129, 303-17.   DOI   ScienceOn
54 Zhao Y, Samal E, Srivastava D (2005). Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature, 436, 214-20.   DOI   ScienceOn
55 Zhou YM, Liu J, Sun W (2014). MiR-130a overcomes geftinib resistance by targeting met in non-small cell lung cancer cell lines. Asian Pac J Cancer Prev, 15, 1391-6.   DOI   ScienceOn
56 Calin GA, Dumitru CD, Shimizu M, et al (2002). Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A, 99, 15524-9.   DOI   ScienceOn
57 Bueno MJ, Perez de Castro I, Malumbres M (2008). Control of cell proliferation pathways by microRNAs. Cell Cycle, 7, 3143-8.   DOI
58 Cai X, Hagedorn CH, Cullen BR (2004). Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA, 10, 1957-66.   DOI   ScienceOn
59 Calin GA, Croce CM (2006). MicroRNA signatures in human cancers. Nat Rev Cancer, 6, 857-66.   DOI   ScienceOn
60 Calin GA, Sevignani C, Dumitru CD, et al (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A, 101, 2999-3004.   DOI   ScienceOn
61 Chen K, Rajewsky N (2007). The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet, 8, 93-103.
62 Chen X, Hu Z, Wang W, et al (2012). Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis. Int J Cancer, 130, 1620-8.   DOI
63 Chen Z, Xu L, Ye X, et al (2013). Polymorphisms of microRNA sequences or binding sites and lung cancer: a meta-analysis and systematic review. PLoS One, 8, 61008.   DOI
64 Dai Y, Huang YS, Tang M, et al (2007). Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus, 16, 939-46.   DOI   ScienceOn
65 Hugon J, Paquet C (2008). Targeting miRNAs in alzheimer's disease. Expert Rev Neurother, 8, 1615-6.   DOI
66 Hu Z, Chen X, Zhao Y, et al (2010). Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol, 28, 1721-6.   DOI   ScienceOn
67 Hu Z, Shu Y, Chen Y, et al (2011). Genetic polymorphisms in the precursor MicroRNA flanking region and non-small cell lung cancer survival. Am J Respir Crit Care Med, 183, 641-8.   DOI
68 Hughes AE, Bradley DT, Campbell M, et al (2011). Mutation altering the miR-184 seed region causes familial keratoconus with cataract. Am J Hum Genet, 89, 628-33.   DOI
69 Johnson SM, Grosshans H, Shingara J, et al (2005). RAS is regulated by the let-7 microRNA family. Cell, 120, 635-47.   DOI   ScienceOn
70 Joshi S, Kotecha S (2007). Lung growth and development. Early Hum Dev, 83, 789-94.   DOI   ScienceOn
71 Keller A, Leidinger P, Gislefoss R, et al (2011). Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis. RNA Biol, 8, 506-16.   DOI
72 Kesanakurti D, Maddirela DR, Chittivelu S, et al (2013). Suppression of tumor cell invasiveness and in vivo tumor growth by microRNA-874 in non-small cell lung cancer. Biochem Biophys Res Commun, 434, 627-33.   DOI
73 Kozuki T, Hisamoto A, Tabata M, et al (2007). Mutation of the epidermal growth factor receptor gene in the development of adenocarcinoma of the lung. Lung Cancer, 58, 30-5.   DOI
74 Liu XH, Lu KH, Wang KM, et al (2012c). MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5. BMC Cancer, 12, 348.   DOI
75 Liu J, Lu KH, Liu ZL, et al (2012a). MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1. BMC Cancer, 12, 519.   DOI
76 Liu L, Shao X, Gao W, et al (2012b). MicroRNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor. FEBS J, 279, 3800-12.   DOI
77 Liu X, Sempere LF, Ouyang H, et al (2010). MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest, 120, 1298-309.   DOI
78 Lu J, Getz G, Miska EA, et al (2005). MicroRNA expression profiles classify human cancers. Nature, 435, 834-8.   DOI   ScienceOn
79 Lu Y, Okubo T, Rawlins E, et al (2008). Epithelial progenitor cells of the embryonic lung and the role of microRNAs in their proliferation. Proc Am Thorac Soc, 5, 300-4.   DOI
80 Lukiw WJ (2007). Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. Neuroreport, 18, 297-300.   DOI
81 Lund E, Guttinger S, Calado A, et al (2004). Nuclear export of microRNA precursors. Science, 303, 95-8.   DOI   ScienceOn
82 Ma L, Teruya-Feldstein J, Weinberg RA (2007). Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature, 449, 682-8.   DOI   ScienceOn
83 Saito Y, Liang G, Egger G, et al (2006). Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell, 9, 435-43.   DOI   ScienceOn
84 Rami-Porta R, Crowley JJ, Goldstraw P (2009). The revised TNM staging system for lung cancer. Ann Thorac Cardiovasc Surg, 15, 4-9.
85 Reinhart BJ, Slack FJ, Basson M, et al (2000). The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature, 403, 901-6.   DOI   ScienceOn
86 Romao JM, Jin W, Dodson MV, et al (2011). MicroRNA regulation in mammalian adipogenesis. Exp Biol Med (Maywood), 236, 997-1004.   DOI
87 Schratt G (2009). microRNAs at the synapse. Nat Rev Neurosci, 10, 842-9.   DOI
88 Siomi H, Siomi MC (2010). Posttranscriptional regulation of microRNA biogenesis in animals. Mol Cell, 38, 323-32.   DOI   ScienceOn
89 Skarn M, Namlos HM, Noordhuis P, et al (2012). Adipocyte differentiation of human bone marrow-derived stromal cells is modulated by microRNA-155, microRNA-221, and microRNA-222. Stem Cells Dev, 21, 873-83.   DOI
90 Smalheiser NR (2003). EST analyses predict the existence of a population of chimeric microRNA precursor-mRNA transcripts expressed in normal human and mouse tissues. Genome Biol, 4, 403.   DOI
91 Sonkoly E, Wei T, Janson PC, et al (2007). MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One, 2, 610.   DOI
92 Sun S, Schiller JH, Gazdar AF (2007). Lung cancer in never smokers--a different disease. Nat Rev Cancer, 7, 778-90.   DOI   ScienceOn
93 Zuo Y, Qiang L, Farmer SR (2006). Activation of CCAAT/ enhancer-binding protein (C/EBP) alpha expression by C/EBP beta during adipogenesis requires a peroxisome proliferator-activated receptor-gamma-associated repression of HDAC1 at the C/ebp alpha gene promoter. J Biol Chem, 281, 7960-7.   DOI
94 Thum T, Galuppo P, Wolf C, et al (2007). MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation, 116, 258-67.   DOI
95 Suzuki HI, Yamagata K, Sugimoto K, et al (2009). Modulation of microRNA processing by p53. Nature, 460, 529-33.   DOI   ScienceOn
96 Tang Y, Liu D, Zhang L, et al (2011). Quantitative analysis of miRNA expression in seven human foetal and adult organs. PLoS One, 6, 28730.   DOI
97 Tatsuguchi M, Seok HY, Callis TE, et al (2007). Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol, 42, 1137-41.   DOI
98 Tuddenham L, Jung JS, Chane-Woon-Ming B, et al (2012). Small RNA deep sequencing identifies microRNAs and other small noncoding RNAs from human herpesvirus 6B. J Virol, 86, 1638-49.   DOI
99 van Rooij E, Sutherland LB, Liu N, et al (2006). A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A, 103, 18255-60.   DOI   ScienceOn
100 Wang Y, Stricker HM, Gou D, et al (2007). MicroRNA: past and present. Front Biosci, 12, 2316-29.   DOI
101 Wu H, Mo YY (2009). Targeting miR-205 in breast cancer. Expert Opin Ther Targets, 13, 1439-48.   DOI   ScienceOn
102 Xu P, Guo M, Hay BA (2004). MicroRNAs and the regulation of cell death. Trends Genet, 20, 617-24.   DOI   ScienceOn